Commonwealth Coat of Arms of Australia
 

 

PB 120 of 2024

National Health (Price and Special Patient Contribution) Amendment Determination 2024 (No. 9)

I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination:

Dated      30 October 2024

NIKOLAI TSYGANOV

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

 

 

Contents

1  Name...................................................1

2  Commencement............................................1

3  Authority................................................1

4  Schedules................................................1

Schedule 1—Amendments 2

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) 2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1  Name

  This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2024 (No. 9).

  This instrument may also be cited as PB 120 of 2024.

2  Commencement

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 November 2024

 

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under section 85B of the National Health Act 1953.

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

 

Schedule 1 – Amendments

 

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)

  1.                  Schedule 1 – entry for Diltiazem

Omit

Diltiazem

Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg

Oral

Cardizem CD

30

6.25

8.02

 

Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg

Oral

Cardizem CD

30

8.45

10.22

 

Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg

Oral

Cardizem CD

30

11.08

12.84

 

Tablet containing diltiazem hydrochloride 60 mg

Oral

Cardizem

90

7.40

9.17

Insert

Diltiazem

Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg

Oral

Cardizem CD

30

5.39

6.92

 

Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg

Oral

Cardizem CD

30

7.29

8.82

 

Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg

Oral

Cardizem CD

30

11.08

12.84

 

Tablet containing diltiazem hydrochloride 60 mg

Oral

Cardizem

90

7.40

9.17


  1.                  Schedule 1 – entry for Irbesartan

Omit

Irbesartan

Tablet 75 mg

Oral

Karvea

30

2.50

5.40

 

Tablet 150 mg

Oral

Avapro

30

2.50

5.78

 

 

 

Karvea

30

2.50

5.78

 

Tablet 300 mg

Oral

Avapro

30

3.50

6.75

 

 

 

Karvea

30

3.50

6.75

Insert

Irbesartan

Tablet 150 mg

Oral

Avapro

30

2.50

5.78

 

 

 

Karvea

30

2.50

5.78

 

Tablet 300 mg

Oral

Avapro

30

3.50

6.75

 

 

 

Karvea

30

3.50

6.75

  1.                  Schedule 1 – omit entry for Macrogol 3350
  2.                  Schedule 1 – entry for Olmesartan with amlodipine

Omit

Olmesartan with amlodipine

Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate)

Oral

Sevikar 20/5

30

3.62

5.58

 

Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate)

Oral

Sevikar 40/5

30

5.18

7.97

 

Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate)

Oral

Sevikar 40/10

30

5.56

7.99

Insert

Olmesartan with amlodipine

Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate)

Oral

Sevikar 20/5

30

3.62

6.41

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate)

Oral

Sevikar 40/5

30

5.18

7.97

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate)

Oral

Sevikar 40/10

30

5.56

8.35

 

  1.                  Schedule 1 – entry for Quinapril

Omit

Quinapril

Tablet 5 mg (as hydrochloride)

Oral

Accupril

30

3.41

7.32

 

Tablet 10 mg (as hydrochloride)

Oral

Accupril

30

3.71

7.62

 

Tablet 20 mg (as hydrochloride)

Oral

Accupril

30

4.58

8.55

Insert

Quinapril

Tablet 5 mg (as hydrochloride)

Oral

Accupril

30

3.41

7.32